HYFT
ImmunoPrecise Antibodies Ltd.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$51.38M
P/E Ratio
—
EPS
$-0.10
Beta
0.64
52W High
$3.25
52W Low
$0.37
50-Day MA
$1.36
200-Day MA
$1.73
Dividend Yield
—
Profit Margin
-43.60%
Forward P/E
—
PEG Ratio
—
About ImmunoPrecise Antibodies Ltd.
MindWalk Holdings Corp. The company is headquartered in Austin, Texas.
Fundamentals
| Revenue (TTM) | $28.08M |
| Gross Profit (TTM) | $16.06M |
| EBITDA | $-10.48M |
| Operating Margin | -88.40% |
| Return on Equity | -58.80% |
| Return on Assets | -18.90% |
| Revenue/Share (TTM) | $0.61 |
| Book Value | $0.23 |
| Price-to-Book | 5.03 |
| Price-to-Sales (TTM) | 1.83 |
| EV/Revenue | 2.284 |
| EV/EBITDA | -4.68 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 52.40% |
| Shares Outstanding | $46.71M |
| Float | $45.34M |
| % Insiders | 9.02% |
| % Institutions | 9.70% |
Analyst Ratings
Consensus ($4.00 target)
2
BuyData last updated: 4/8/2026